Q4 2021 Holdings
Filed 2022-02-14 | 9 holdings | $208.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $208.5M | 9,699,925 | 99.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $116.9K | 2,740,411 | 0.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $99.5K | 5,011,536 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $45.9K | 2,171,664 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $33.1K | 2,303,310 | 0.0% |
| Impel Neuropharma Inc | COM | 45258K109 | $23.8K | 2,759,791 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $15.7K | 2,608,167 | 0.0% |
| Checkmate Pharmaceuticals in | COM | 162818108 | $10.5K | 3,673,374 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.1K | 161,897 | 0.0% |